Drug Database
Back to search

France· FR:67978055

DIMETHYL FUMARATE ACCORD 120 mg, gélule gastro-résistante

A dimethyl fumarate product containing fumarate de diméthyle, registered in France by ACCORD HEALTHCARE (ESPAGNE), on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC L04AX07

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedDIMETHYL FUMARATE ACCORD 120 mg, gélu…ATCL04AX07REGISTER NO.FR:67978055PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fumarate de diméthyleAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dimethyl fumarate is registered in 13 of 19 countries.

Countries holding a registration under ATC L04AX07 (dimethyl fumarate), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose
Search dimethyl fumarate products by name

Dimethyl fumarate · ATC L04AX07

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dimethyl fumarate costs, country by country.

Normalised to the WHO defined daily dose (0.48 g), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Dimethyl fumarate · price per daily dose (0.48 g)

USD · FX 28 Sept 2026

  • IT Italy$20.95
  • CH Switzerland$17.36
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
FUMARATE DE DIMÉTHYLE
Manufacturer
ACCORD HEALTHCARE (ESPAGNE)
Country
France (FR)
ATC code
L04AX07
ATC class
Dimethyl fumarate
Defined daily dose
0.48 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930295700
    plaquette PVC polyéthylène PVDC aluminium de 14 gélules
    EUR 86.13

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

317 interactions on record for dimethyl fumarate.

Graded by severity as the source publishes them — 32 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dimethyl fumarate against other medicinesHow interaction checks work

Dimethyl fumarate · interactions on record

317 records

  • 32 severe
  • 285 moderate

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • CladribineL01BB04severe
  • PexidartinibL01EX15severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under L04AX07

Dimethyl fumarate, as other registers publish it.

All dimethyl fumarate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/411c7057-1435-488c-90a2-883e7f9c20bd
GET /v1/drugs/411c7057-1435-488c-90a2-883e7f9c20bd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "67978055",
  "date_amm": "2024-04-22",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/24/1811",
  "substance": "FUMARATE DE DIMÉTHYLE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "gélule gastro-résistant(e)",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about dimethyl fumarate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console